ArticleBMC research notes2026
Prevalence and determinants of dyslipidemia among residents of Kurdistan Region of Iraq; a community-based study.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCardiovascular diseases (CVD) remain the leading cause of global mortality, with dyslipidemia being a major modifiable risk factor. Dyslipidemia remains inadequately studied in developing countries like Iraq, so this study aims to assess the prevalence and determinants of dyslipidemia among residents of the Kurdistan Region of Iraq. This cross-sectional study was conducted between January and April 2025 and included 1132 participants aged ≥ 18 years. Dyslipidemia was defined based on prior confirmed diagnosis with documented laboratory, chronic disease registry identification card or specialist physician report.
resultsThe overall prevalence of dyslipidemia was 13.5%, lower than neighboring regions, with higher prevalence in men (15.8%) compared to women (9.9%). Significant determinants of dyslipidemia in multivariable logistics regression included low education (OR 3.197, 95% CI: 2.257-4.527), obesity (4.039, 2.464-6.619), hypertension (6.301, 4.205-9.44), and ischemic heart disease (11.21, 6.16-20.43). These findings underscore the need for public health initiatives focused on promoting healthy lifestyles, particularly in at-risk populations, to reduce the burden of dyslipidemia and prevent cardiovascular events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.